
An update from Pro Medicus Limited ( ($AU:PME) ) is now available. The release concerns Pro Medicus Limited, although it provides no additional information on the company’s industry, products or
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| PMCUF | Pro Medicus Limited | 131.10 | -29.02 | -18.12% |
| Name | Price | % Change | |
|---|---|---|---|
| $131.10 | -18.12% |

An update from Pro Medicus Limited ( ($AU:PME) ) is now available. The release concerns Pro Medicus Limited, although it provides no additional information on the company’s industry, products or

Pro Medicus Limited ( ($AU:PME) ) just unveiled an update. Pro Medicus Limited has invited shareholders to its 2026 Annual General Meeting, which will be held as a hybrid event

The latest update is out from Pro Medicus Limited ( ($AU:PME) ). Pro Medicus’ U.S. subsidiary Visage Imaging has secured a seven-year, A$24 million contract to supply its cloud-based Visage

Pro Medicus Limited ( ($AU:PME) ) has shared an announcement. Pro Medicus has scheduled its 2026 Annual General Meeting for 25 November 2026 at a venue in Hawthorn, Victoria, with

Pro Medicus Limited ( ($AU:PME) ) has shared an announcement. Pro Medicus has appointed technology executive Tim Reed as an independent non-executive director, effective 1 October 2026, adding three decades

Pro Medicus Limited ( ($AU:PME) ) has issued an announcement. State Street Global Advisors and several affiliated entities have lodged a notice indicating they have ceased to be substantial holders

Pro Medicus Limited ( ($AU:PME) ) has shared an update. Pro Medicus’ U.S. subsidiary Visage Imaging has secured a seven-year, A$25 million contract with Valley Health, a six-hospital system serving

Pro Medicus Limited ( ($AU:PME) ) just unveiled an announcement. Pro Medicus has reaffirmed its commitment to integrated reporting by aligning its Annual Report with the International Integrated Reporting Framework,

The latest update is out from Pro Medicus Limited ( ($AU:PME) ). Pro Medicus reported full-year results that met internal expectations, delivering higher revenue and profit on a constant currency

Pro Medicus Limited ( ($AU:PME) ) just unveiled an update. Pro Medicus Limited has lodged its updated corporate governance statement for the year ended 30 June 2026, confirming it is
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| buy | Reiterated | Nov 15, 2026 | ||||
| hold | Reiterated | Oct 20, 2026 | ||||
| buy | Reiterated | Oct 19, 2026 | ||||
| buy | Reiterated | Sep 23, 2026 | ||||
| buy | Reiterated | Aug 20, 2026 | ||||
| buy | Reiterated | Aug 19, 2026 | ||||
| hold | Reiterated | Aug 18, 2026 | ||||
| buy | Reiterated | May 12, 2026 |
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Feb 16, 2027TBA | $13.49B | $0.59 | $113.56M | 0.61 | 76.30 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.